RBC Capital raised the firm’s price target on Ligand (LGND) to $143 from $141 and keeps an Outperform rating on the shares. The company has accumulated a diverse set of royalty generating assets along with the Captisol technology platform and currently has 12 major commercial-stage royalty streams and more than 90 additional active programs with economic rights, the analyst tells investors in a research note. Ligand’s strong free cash flow generation allows it to comfortably make future royalty acquisitions without relying on external capital, the firm added.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio